美拉加群 美拉加群
CAS 159776-70-2 MFCD00945676
                 信息真实价格透明   
                 资金保障   
                 专业采购外包团队在线服务   
                
                
                 信息真实价格透明   
                 资金保障   
                 专业采购外包团队在线服务   
                  
                
                 品牌质保精细包装   
                 现货库存   
                 一流品牌服务   
                
            分类
- Aromatics
 - Chiral Reagents
 - Pharmaceuticals
 - Intermediates & Fine Chemicals,
 
产品应用
- Synthetic thrombin inhibitor. Thrombin mutant anticoagulant antagonist. Antithrombotic.
 
相关文献及参考
- [2]. Mehta JL, et al. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery. J Cardiovasc Pharmacol. 1998 Mar;31(3):345-51.
 - Carlsson, S., et al.: Thromb. Res., 115, 9 (2005),
 - Dewanjee, M., et al.: J. Nucl. Med., 22, 981 (1981),
 - Goodman, S., et al.: J. Biomed. Mater. Res., 45, 240 (1999),
 - [1]. Eriksson M, et al. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Expert Opin Investig Drugs. 2000 May;9(5):1129-37.
 - [1]. Eriksson M, et al. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Expert Opin Investig Drugs. 2000 May;9(5):1129-37.
 - [2]. Mehta JL, et al. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery. J Cardiovasc Pharmacol. 1998 Mar;31(3):3
 
